Top-News
Verkauf, spezialisiert USA

9 Meters Biopharma News

Aktie
WKN:  A3DWPZ ISIN:  US6544052086 US-Symbol:  NMTRQ
-    $
+0,00 $
0,00%
10.05.24 21:21:16
Handeln Depot/Watchlist
Aktienanzahl *
12,78 Mio.
Marktkapitalisierung *
12 €
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 18.10.2022

9 Meters Biopharma News

27.09.22 - PR Newswire
Thinking about buying stock in American Virtual Cloud Technologies, Bed Bath & Beyond, Lucid Group, Plug Power, or 9 Meters Biopharma?
Thinking about buying stock in American Virtual Cloud Technologies, Bed Bath & Beyond, Lucid Group, Plug Power, or 9 Meters Biopharma? PR Newswire
05.01.22 - PR Newswire
Thinking about buying stock in 9 Meters Biopharma, TherapeuticsMD, Cameco Corp, Nikola Corp, or Comstock Mining?
Thinking about buying stock in 9 Meters Biopharma, TherapeuticsMD, Cameco Corp, Nikola Corp, or Comstock Mining? PR Newswire
04.01.22 - ACCESSWIRE
9 Meters Biopharma, Inc. to Participate in the following Virtual January Investor Conferences
RALEIGH, NC / ACCESSWIRE / January 4, 2022 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR) (the "Company"), a clinical-​stage company pioneering novel treatments for people with ...
03.01.22 - ACCESSWIRE
9 Meters Biopharma Appoints Sarah Liu as Chief Commercial Officer and Al Medwar as Senior Vice President of Investor Relations & Corporate Communications
RALEIGH, NC / ACCESSWIRE / January 3, 2022 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR),a clinical-​stage company pioneering novel treatments for people with rare or debilitating ...
28.12.21 - PR Newswire
Thinking about buying stock in Energy Focus, 9 Meters Biopharma, Aditxt, ReTo Eco-Solutions, or Aeva Technologies?
Thinking about buying stock in Energy Focus, 9 Meters Biopharma, Aditxt, ReTo Eco-​Solutions, or Aeva Technologies? PR Newswire
15.12.21 - ACCESSWIRE
9 Meters Biopharma, Inc. Awards Unrestricted Educational Grant Funding to Carol Rees Parrish, M.S., RDN, for Short Bowel Syndrome Education
RALEIGH, NC / ACCESSWIRE / December 15, 2021 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR) (the "Company"), a clinical-​stage company pioneering novel treatments for people ...
15.11.21 - ACCESSWIRE
9 Meters Biopharma Provides Business Update and Reports Financial Results for the Third Quarter 2021
- Phase 2 vurolenatide VIBRANT study enrollment anticipated to be completed before year-end; topline results for short bowel syndrome expected in Q1 2022 - - Larazotide Phase 3 ...
10.11.21 - ACCESSWIRE
9 Meters Biopharma, Inc. Announces Immuno-Oncology Collaboration with Gustave Roussy for NM-102, a Gut Microbiome Modulator
Collaboration builds upon previous positive preclinical data warranting further investigation of NM-102, a potential novel therapy to enhance immune checkpoint inhibitor effect IND-...
09.11.21 - ACCESSWIRE
9 Meters Biopharma, Inc. to Present at the 12th Annual Jefferies London Healthcare Conference
In-Person Dates: November 16 th -17 th Virtual Dates: November 18 th -19 th RALEIGH, NC / ACCESSWIRE / November 9, 2021 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a ...
26.10.21 - ACCESSWIRE
9 Meters Biopharma, Inc. Presents Pharmacokinetic Data from Phase 1b/2a Study with Vurolenatide, Currently in Phase 2 for Short Bowel Syndrome, at the American College of Gastroenterology (ACG) 2021 Annual Scientific Meeting
- Vurolenatide's half-life is consistent with twice-​monthly dosing - - Top-line results from the ongoing Phase 2 VIBRANT trial on track to be reported before year's end -
19.10.21 - ACCESSWIRE
9 Meters Biopharma, Inc. to Present Data on Therapeutic Candidate in Short Bowel Syndrome at the American College of Gastroenterology (ACG) 2021 Annual Scientific Meeting
RALEIGH, NC / ACCESSWIRE / October 19, 2021 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-​stage company pioneering novel treatments for people with rare or ...
04.10.21 - ACCESSWIRE
9 Meters Biopharma, Inc. Appoints Samantha Ventimiglia to Board of Directors
RALEIGH, NC / ACCESSWIRE / October 4, 2021 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-​stage company pioneering novel treatments for people with rare or ...
27.09.21 - ACCESSWIRE
9 Meters Biopharma, Inc. Announces Partnership with Non-Profit Gluten-Free Food Pantry Organization Mend Hunger
RALEIGH, NC / ACCESSWIRE / September 27, 2021 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR) (the "Company"), a clinical-​stage company pioneering novel treatments for people ...
12.07.21 - PR Newswire
Thinking about buying stock in Tencent Music Entertainment, Delta Air Lines, Iterum Therapeutics, HP, or 9 Meters Biopharma?
Thinking about buying stock in Tencent Music Entertainment, Delta Air Lines, Iterum Therapeutics, HP, or 9 Meters Biopharma? PR Newswire
09.07.21 - PR Newswire
Thinking about buying stock in Dare Bioscience, Newegg, Zynga, 9 Meters Biopharma, or Kohl's?
Thinking about buying stock in Dare Bioscience, Newegg, Zynga, 9 Meters Biopharma, or Kohl's? PR Newswire
04.06.21 - PR Newswire
Thinking about buying stock in Progenity, 9 Meters Biopharma, Corsair Gaming, Sundial Growers, or Zomedica?
Thinking about buying stock in Progenity, 9 Meters Biopharma, Corsair Gaming, Sundial Growers, or Zomedica? PR Newswire
26.04.21 - PR Newswire
Thinking about buying stock in AMC Entertainment, 22nd Century Group, Zosano Pharma, Pieris Pharmaceuticals, or 9 Meters Biopharma?
Thinking about buying stock in AMC Entertainment, 22nd Century Group, Zosano Pharma, Pieris Pharmaceuticals, or 9 Meters Biopharma? PR Newswire
23.04.21 - PR Newswire
Thinking about buying stock in Jaguar Health, Ocugen, Microvision, 9 Meters Biopharma, or Hall of Fame Resort & Entertainment?
Thinking about buying stock in Jaguar Health, Ocugen, Microvision, 9 Meters Biopharma, or Hall of Fame Resort & Entertainment? PR Newswire
20.04.21 - PR Newswire
Thinking about buying stock in Sundial Growers, 22nd Century Group, Kansas City Southern, Fisker, or 9 Meters Biopharma?
Thinking about buying stock in Sundial Growers, 22nd Century Group, Kansas City Southern, Fisker, or 9 Meters Biopharma? PR Newswire
07.04.21 - PR Newswire
Thinking about buying stock in 9 Meters Biopharma, Envista Holdings, Ouster Inc, Reed's, or Akebia Therapeutics?
Thinking about buying stock in 9 Meters Biopharma, Envista Holdings, Ouster Inc, Reed's, or Akebia Therapeutics? PR Newswire

Newssuche

Videos

newspaper
07.05.24 -4,91%
Technical Trading: DAX Long kurzfristig
DAX Long Typ: Turbo Open End WKN: NG8K9X Hebel: 26 Laufzeit: OpenEnd Einstieg: Market ... Mehr »